BENH.US Bio-En Holdings Corp
- Market cap
- USD 170K
- P/E
- -
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.
Is BENH.US undervalued?
Graham numberThe Graham number of Bio-En Holdings Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Bio-En Holdings Corp fundamental analysis
No fundamental analysis for Bio-En Holdings Corp yet.
Bio-En Holdings Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Bio-En Holdings Corp
Bio-En Holdings Corp does not have significant operations. Previously, it focused on building, operating, and maintaining a bio-mass to energy facility on the Island of Malta. The company was formerly known as Olivia Inc. and changed its name to Bio-En Holdings Corp in August 2014. The company was incorporated in 2011 and is based in Secaucus, New Jersey.
Full company profileBio-En Holdings Corp financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Bio-En Holdings Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 0.00 | 194.00 | 168.00 | 168.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | - |
| Gross Profit | - | 0.00 | -19.2K | -19.3K | 168.00 | 0.00 | - | - | - | - | - |
| Operating Income | -37.9K | -227K | -186K | -159K | 256K | -88.4K | -126K | 125K | -105K | - | - |
| EBITDA | -37.9K | -198K | -186K | -159K | 329K | -88.4K | -126K | -65.0K | -73.9K | - | - |
| Net Income | -37.9K | -227K | -220K | -196K | 309K | -88.4K | -126K | -445K | -10.4K | - | - |
| EPS | 0.00 | -0.01 | -0.01 | -0.01 | 0.01 | 0.00 | 0.00 | -0.01 | 0.00 | - | - |
| Balance Sheet | |||||||||||
| Total Assets | 33.2K | 266K | 247K | 227K | 60.00 | 11.6K | 242K | 26.7K | 15.6K | - | - |
| Total Liabilities | 13.7K | 369K | 569K | 745K | 210K | 73.2K | 429K | 469K | 500K | - | - |
| Shareholders' Equity | 19.5K | -103K | -322K | -518K | -209K | -61.6K | -188K | -443K | -485K | - | - |
| Cash & Short-term Investments | 32.6K | 1.50K | 1.30K | 1.14K | 60.00 | 5.42K | 420.00 | 11.7K | 15.6K | - | - |
| Total Debt | 593.00 | 28.4K | 56.4K | 84.2K | 70.0K | 35.8K | 380K | 376K | 376K | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -25.4K | -20.8K | -28.2K | -28.0K | 13.1K | -197K | -349K | 15.3K | 3.92K | - | - |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - |
| Free Cash Flow | -25.4K | -20.8K | -28.2K | -28.0K | 13.1K | -197K | -349K | 15.3K | 3.92K | - | - |
| Ratios | |||||||||||
| ROE | -194.2% | - | - | - | - | - | - | - | - | - | - |
| ROA | -114.3% | -85.2% | -89.1% | -86.3% | 514,471.7% | -759.3% | -52.2% | -1,667.7% | -66.4% | - | - |
| Net Profit Margin | - | - | -113,402.1% | -116,666.7% | 183,739.9% | - | - | - | - | - | - |
| Debt to Equity | 0.03x | - | - | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Bio-En Holdings Corp dividends
Bio-En Holdings Corp has not paid dividends in the last 10 fiscal years.
Last stock split: 6.316:1 on Aug 13, 2014.
Who owns Bio-En Holdings Corp
- Insiders 59.91%
- Institutions 0.00%
- Public & others 40.09%
- Shares outstanding 77.4M
- Free float 31.0M
Bio-En Holdings Corp company profile
- Company name
- Bio-En Holdings Corp
- Ticker
- BENH.US
- Exchange
- USA Stocks
- Sector
- Financial Services
- Industry
- Capital Markets
- Fiscal year end
- December
- Address
- 1 County Road, Secaucus, NJ, United States, 07094
- Phone
- 845 364 7151
- Website
- -
About Bio-En Holdings Corp
Bio-En Holdings Corp does not have significant operations. Previously, it focused on building, operating, and maintaining a bio-mass to energy facility on the Island of Malta. The company was formerly known as Olivia Inc. and changed its name to Bio-En Holdings Corp in August 2014. The company was incorporated in 2011 and is based in Secaucus, New Jersey.
Bio-En Holdings Corp management
4- Mr. Ossie WeitzmanChief Financial Officer · born 1955
- Mr. Baruch AdikaChairman, CEO & President · born 1979
- Mr. Alon ShanyExecutive VP & Director · born 1995
- Mr. Bruce W. MinskyCorporate Secretary · born 1964